Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
We identified a novel heterozygous mutation, W68R, in the Kir6.2 subunit of the ATP-sensitive potassium (KATP) channel, in a patient with transient neonatal diabetes. This tryptophan is absolutely conserved in mammalian Kir channels. The functional effects of mutations at residue 68 of Kir6.2 were studied by heterologous expression in Xenopus oocytes, and by homology modelling. We found the Kir6.2-W68R mutation causes a small reduction in ATP inhibition in the heterozygous state and an increase in the whole-cell KATP current. This can explain the clinical phenotype of the patient. The effect of the mutation was not charge or size dependent, the order of potency for ATP inhibition being W<M∼L<R∼E∼K∼A<C∼F<Y. Replacement with tyrosine (Y) rendered the KATP channel almost completely insensitive to ATP block, dramatically increased the channel open probability, and affected the interaction of Kir6.2 with SUR1. In different Kir crystal structures the residue corresponding to W68 adopts two distinct positions. In one state, the tryptophan lies in a position that would impede movement of transmembrane domain 2 (TM2) and opening of the gate. In the other state, it is flipped out, enabling movement of TM2. We therefore hypothesise that W68 may act as a molecular'gatekeeper' for Kir channels.
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995, Pubmed
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995,
Pubmed Antcliff,
Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit.
2005,
Pubmed Ashcroft,
Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells.
,
Pubmed Ashcroft,
The Walter B. Cannon Physiology in Perspective Lecture, 2007. ATP-sensitive K+ channels and disease: from molecule to malady.
2007,
Pubmed Ashcroft,
New uses for old drugs: neonatal diabetes and sulphonylureas.
2010,
Pubmed Babenko,
Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
2006,
Pubmed Clark,
Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin.
2010,
Pubmed Clement,
Association and stoichiometry of K(ATP) channel subunits.
1997,
Pubmed Cohen,
Four distances between pairs of amino acids provide a precise description of their interaction.
2009,
Pubmed de Wet,
Studies of the ATPase activity of the ABC protein SUR1.
2007,
Pubmed Drain,
KATP channel inhibition by ATP requires distinct functional domains of the cytoplasmic C terminus of the pore-forming subunit.
1998,
Pubmed
,
Xenbase Drain,
Concerted gating mechanism underlying KATP channel inhibition by ATP.
2004,
Pubmed
,
Xenbase Flanagan,
Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.
2007,
Pubmed Girard,
Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
2006,
Pubmed
,
Xenbase Gloyn,
Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
2004,
Pubmed
,
Xenbase Gribble,
Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase Gribble,
Sulphonylurea action revisited: the post-cloning era.
2003,
Pubmed Gribble,
MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit.
1998,
Pubmed
,
Xenbase Gribble,
The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide.
1997,
Pubmed
,
Xenbase Haider,
Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis.
2007,
Pubmed Hattersley,
Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.
2005,
Pubmed Koster,
The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.
2008,
Pubmed Kuo,
Crystal structure of the potassium channel KirBac1.1 in the closed state.
2003,
Pubmed Long,
Voltage sensor of Kv1.2: structural basis of electromechanical coupling.
2005,
Pubmed McTaggart,
The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet.
2010,
Pubmed Mikhailov,
3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1.
2005,
Pubmed Miki,
Roles of KATP channels as metabolic sensors in acute metabolic changes.
2005,
Pubmed Mlynarski,
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.
2007,
Pubmed Nichols,
Adenosine diphosphate as an intracellular regulator of insulin secretion.
1996,
Pubmed Nichols,
KATP channels as molecular sensors of cellular metabolism.
2006,
Pubmed Nishida,
Crystal structure of a Kir3.1-prokaryotic Kir channel chimera.
2007,
Pubmed Pearson,
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
2006,
Pubmed
,
Xenbase Proks,
Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
2004,
Pubmed
,
Xenbase Proks,
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
2006,
Pubmed
,
Xenbase Sali,
Comparative protein modelling by satisfaction of spatial restraints.
1993,
Pubmed Schulze,
Phosphatidylinositol 4,5-bisphosphate (PIP2) modulation of ATP and pH sensitivity in Kir channels. A tale of an active and a silent PIP2 site in the N terminus.
2003,
Pubmed Shimomura,
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
2007,
Pubmed
,
Xenbase Shyng,
Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor.
1997,
Pubmed Shyng,
Structural determinants of PIP(2) regulation of inward rectifier K(ATP) channels.
2000,
Pubmed Slingerland,
Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.
2006,
Pubmed Slingerland,
Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.
2008,
Pubmed Stansfeld,
PIP(2)-binding site in Kir channels: definition by multiscale biomolecular simulations.
2009,
Pubmed Tao,
Crystal structure of the eukaryotic strong inward-rectifier K+ channel Kir2.2 at 3.1 A resolution.
2009,
Pubmed
,
Xenbase Tarasov,
A Kir6.2 mutation causing neonatal diabetes impairs electrical activity and insulin secretion from INS-1 beta-cells.
2006,
Pubmed Tarasov,
Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes.
2007,
Pubmed
,
Xenbase Tucker,
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
1997,
Pubmed
,
Xenbase
